XML 60 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Investments
3 Months Ended
Mar. 31, 2015
Notes to Financial Statements  
Note 4 - Investments

The cost and fair value of investments classified as available-for-sale are as follows:

 

March 31, 2015   Cost    

Unrealized

Gains

   

Unrealized

Losses

   

Fair

Value

 
Common Stocks & ETFs   $ 1,044,604     $ 20,042     $ (86,266 )   $ 978,380  
Mutual Funds     58,330             (3,667 )     54,663  
Preferred Securities     97,405       3,315             100,720  
Corporate Bonds     2,046,093       6,726       (148,079 )     1,904,740  
Total   $ 3,246,432     $ 30,083     $ (238,012 )   $ 3,038,503  

  

December 31, 2014   Cost    

Unrealized

Gains

   

Unrealized

Losses

   

Fair

Value

 
Common Stocks & ETFs   $ 530,328     $ 19,608     $ (64,046 )   $ 485,890  
Mutual Funds     445,337       0       (10,624 )     434,713  
Preferred Securities     180,120       195       (2,075 )     178,240  
Corporate Bonds     1,948,596       1,880       (270,179 )     1,680,297  
Total   $ 3,104,381     $ 21,683     $ (346,924 )   $ 2,779,140  

  

Proceeds from the sale of investments were $693,223 and $554,609 for the three months ended March 31, 2015 and 2014, respectively.

 

Gross gains of $5,502 and $19,651 and gross losses of $10,595 and $14,843 were realized on these sales during the three months ended March 31, 2015 and 2014, respectively.

 

The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at March 31, 2015 and December 31, 2014:

 

    Less Than 12 Months     12 Months or Greater     Total  
March 31, 2015   Fair Value     Unrealized Losses     Fair Value     Unrealized Losses     Fair Value     Unrealized Losses  
Common Stocks & ETFs   $ 458,306     $ (43,834 )   $ 159,492     $ (42,432 )   $ 617,798     $ (86,265 )
Mutual Funds     54,663       (3,667 )     0       0       54,663       (3,667 )
Preferred Securities     0       0       0       0       0       0  
Corporate Bonds     1,922,104       (60,687 )     489,394       (87,392 )     2,411,498       (148,079 )
    $ 2,435,073     $ (108,188 )   $ 648,886     $ (129,824 )   $ 3,083,960     $ (238,012 )

 

    Less Than 12 Months     12 Months or Greater     Total  
December 31, 2014   Fair Value     Unrealized Losses     Fair Value     Unrealized Losses     Fair Value     Unrealized Losses  
Common Stocks & ETFs   $ 162,268     $ (49,053 )   $ 141,417     $ (14,993 )   $ 303,685     $ (64,046 )
Mutual Funds     434,713       (10,624 )     0       0       434,713       (10,624 )
Preferred Securities     80,640       (2,075 )     0       0       80,640       (2,075 )
Corporate Bonds     1,056,140       (194,641 )     497,277       (75,538 )     1,553,417       (270,179 )
    $ 1,733,761     $ (256,393 )   $ 638,694     $ (90,531 )   $ 2,372,455     $ (346,924 )

  

The Company’s investments in equity securities, mutual funds, preferred securities, and corporate bonds consist of investments in common stock, preferred stock, structured notes and other debt securities of companies in various industries. During the first quarter of 2015, the Company recorded other-than-temporary impairment losses of approximately $180,000 with respect to three structured notes.  The impairment loss is included in “other income (expense), net” in the accompanying consolidated statements of income and comprehensive income. The structured notes allow the issuer to settle at less than par in certain circumstances. In reaching a conclusion to record these other-than-temporary impairment losses, the Company evaluated the near-term prospects of the issuers and determined it was probable the issuers would have the ability to settle the bonds for an amount less than par value at maturity. With respect to one other corporate bond with unrealized losses, the Company evaluated the near-term prospects of the issuer in relation to the severity and duration of the impairment.  Based on that evaluation and the Company’s ability and intent to hold these investments for a reasonable period of time sufficient for a forecasted recovery of fair value, the Company did not consider the investment to be other-than-temporarily impaired at March 31, 2015.